NCT02385292View on ClinicalTrials.gov

Multicenter Trial Evaluating Quality of Tears Produced by Nasal Neurostimulation

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Dry Eye Syndromes
Interventions
DEVICE

Oculeve Intranasal Lacrimal Neurostimulator

The Oculeve Intranasal Lacrimal Neurostimulator applies a small electrical current to gently activate the body's natural tear production system.

Trial Locations (2)

77030

Baylor College of Medicine, Department of Ophthalmology, Houston

95815

Grutzmacher, Lewis & Sierra, Sacramento

Sponsors

Lead Sponsor

Oculeve, Inc.
All Listed Sponsors
lead

Oculeve, Inc.

INDUSTRY